In a note issued short while ago, Aegis analyst Difei Yang dropped coverage of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI). Her previous Hold rating and price …
Novocure Ltd (NASDAQ:NVCR) shares were on a close to 40% surge Monday, after the device maker announced positive survival data from a phase 2 pilot trial …
Though Trevena Inc (NASDAQ:TRVN) released positive Phase III trial data read-outs yesterday, shares are dropping 8% today. From the viewpoint of Aegis analyst …
In a research note released Friday, Aegis analyst Difei Yang reiterated coverage on shares of IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) with a Buy rating and …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares jumped over 50%, after the glaucoma drug company announced positive top-line efficacy results from its Phase III “Mercury 1” …
Brean Capital analyst Difei Yang was out today with a few insights on Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), following the news that the U.
In a research report issued Friday, Brean Capital analyst Difei Yang downgraded shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) from Buy to Hold, after the pharma …
Analyst Difei Yang of Brean Capital feels reassured about the Relypsa Inc’s (NASDAQ:RLYP) ascending success, calling attention to its up-and-coming potassium-binding Valtassa, a beta …
In a research report published Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), with …
In a research report issued Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), while …
